Table 1 Demographic characteristicsa, b
Characteristics | Clinical pathway, n = 238 | No intervention, n = 238 | Between-group difference, OR (95% CI) | P-valueb |
|---|---|---|---|---|
Age, years (mean ± SD) | 74.5 ± 10.8 | 74.0 ± 11.7 | - | 0.61 |
Male gender | 138/238 (58.0) (51.4 to 64.3) | 98/238 (41.2) (34.9 to 47.7) | 1.97 (1.35 to 2.89) | < 0.001 |
Previous stroke | 50/215 (23.3) (17.8 to 29.5) | 57/207 (27.5) (21.6 to 34.2) | 0.80 (0.50 to 1.27) | 0.32 |
Current smoking status | 29/229 (12.7) (12.4 to 22.5) | 25/219 (11.4) (3.9 to 11.0) | 1.13 (0.61 to 2.07) | 0.77 |
Hypertension | 132/229 (57.6) (51.0 to 64.1) | 103/219 (47.0) (40.3 to 53.9) | 1.53 (1.04 to 2.27) | 0.03 |
Heart failure | 86/229 (37.5) (30.0 to 42.8) | 78/219 (35.6) (30.6 to 43.8) | 1.09 (0.73 to 1.63) | 0.69 |
Coronary heart disease | 21/229 (9.2) (5.8 to 13.7) | 29/219 (13.2) (9.1 to 18.5) | 0.66 (0.35 to 1.25) | 0.18 |
Peripheral vasculopathy | 73/229 (31.9) (25.9 to 38.3) | 46/219 (21.0) (15.8 to 27.0) | 1.76 (1.12 to 2.76) | < 0.01 |
Diabetes mellitus | 52/229 (22.7) (17.4 to 28.7) | 73/219 (31.5) (27.1 to 40.0) | 0.59 (0.38 to 0.91) | 0.01 |
Diabetes mellitus (organ pathology) | 7/229 (3.1) (1.2 to 6.2) | 9/219 (4.1) (1.9 to 7.8) | 0.74 (0.24 to 2.20) | 0.62 |
COPD | 24/229 (10.5) (6.8 to 15.2) | 51/219 (23.3) (17.9 to 29.5) | 0.48 (0.28 to 0.83) | < 0.01 |
Cerebrovascular pathology | 60/229 (26.2) (20.6 to 32.4) | 82/219 (37.4) (31.0 to 44.2) | 0.59 (0.39 to 0.90) | 0.01 |
Pressure ulcer | 4/229 (1.8) (0.5 to 4.4) | 11/219 (5.0) (2.5 to 8.8) | 0.35 (0.09 to 1.22) | 0.06 |
Hemiplegy | 16/229 (7.0) (4.0 to 11.1) | 22/219 (10.1) (6.4 to 14.8) | 0.67 (0.33 to 1.38) | 0.31 |
Nephropathy | 10/229 (4.4) (2.1 to 7.9) | 13/219 (5.9) (3.2 to 9.9) | 0.72 (0.29 to 1.81) | 0.52 |
Dementia | 24/229 (10.5) (6.8 to 15.2) | 10/219 (6.0) (2.2 to 8.2) | 2.45 (1.08 to 5.63) | 0.02 |
Hepatopathy | 7/229 (3.1) (1.2 to 6.2) | 6/219 (2.7) (1.0 to 5.9) | 1.12 (0.33 to 1.82) | 1 |
   Cancer |  |  |  |  |
Solid metastasis | 2/229 (0.9) (0.1 to 3.1) | 3/219 (1.4) (0.3 to 4.0) | 0.63 (0.07 to 4.70) | 0.68 |
Leukemia | 2/229 (0.9) (0.1 to 3.1) | 3/219 (1.4) (0.3 to 4.0) | 0.63 (0.07 to 4.70) | 0.68 |
Lymphoma | 1/229 (0.4) (0.0 to 2.4) | 0/219 (0.0) (0.0 to 1.7) | 1.08 (0.14 to 1.92) | 1 |
Others | 11/229 (4.8) (2.4 to 8.4) | 19/219 (8.7) (3.8 to 14.7) | 0.53 (0.23 to 1.21) | 0.10 |